NL-OMON49625
Withdrawn
N/A
Excitatory/Inhibitory imbalance in autism spectrum disorder - Equilibrium
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- ASD
- Sponsor
- Radboud Universitair Medisch Centrum
- Enrollment
- 60
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years or older
- •Dutch speaking
- •Normal or corrected\-to\-normal vision
- •Willingness and ability to understand nature and content of the study
- •An established clinical diagnosis of autism spectrum disorder according to the
- •DSM\-5 criteria (patient group only)
Exclusion Criteria
- •History of brain surgery or epilepsy
- •History of neurological treatment
- •Any acute or chronic neurological disorders.
- •Claustrophobia
- •MRI incompatibility (metal parts in upper body, implants, medical devices or
- •medicinal plasters)
- •There is presence of a diagnosis of psychosis or bipolar disorder (patient
- •There is presence of any DSM\-5 axis I or axis II psychiatric disorders (control
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Phase 2
A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum DisorderIrritability Associated With Autism Spectrum DisorderAutism Spectrum DisorderASDNCT05733390Jazz Pharmaceuticals1
Active, Not Recruiting
Phase 1
Investigation of the cause of autism using the medication BumetanideEUCTR2021-003514-39-SEGillberg Neuropsychiatry Centre50
Recruiting
Phase 1
This study aims to find out if autism and hyperactivity (ADHD) occur together and to what extent.CTRI/2017/11/010486Psychiatry department GMCH
Not Yet Recruiting
N/A
Executive control functions in autism spectrum disordersNL-OMON29914Katholieke Universiteit Nijmegen135
Completed
Phase 3
Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASDAutism Spectrum DisorderNCT05439616AbbVie161